Skip to the main content.

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

Tom French : 28 July 2025

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

This article traces the evolution of API-in-capsule (AIC) technology, from its early disruption of traditional formulation through the Xcelodose® system, to its reinvention in 3P innovation’s Fill2Weight platform. The authors explore how AIC has shifted from a risky bet to a scalable solution for modern drug development. Looking ahead, they highlight the transformative role AIC can play in personalised medicine, oncology, and DPI, where flexibility and precision are key to success.

Authors:

  • Tom French (Head of Process Technology- 3P innovation)
  • Dave Miller (CSO- AustinPx)
  • Derek Hennecke (CEO- Grand River Aseptic Manufacturing)

READ THE WHITEPAPER HERE
CAR-T cell therapy for cancer: The patient's in the process

CAR-T cell therapy for cancer: The patient's in the process

Georgia Lewis: 29 July 2026

Around 1,000 people are diagnosed with cancer every day in the UK. Fortunately, outcomes continue to improve, with around half of those diagnosed...

robotics cell gene
Read More
Engineering Challenges in Designing Pharmaceutical Isolators

Engineering Challenges in Designing Pharmaceutical Isolators

James Lau: 7 July 2026

In this latest blog, James Lau, one of 3P’s Project Engineers, tells us all about barrier systems across a range of areas. Specifically taking a...

Read More
Formulation Freedom in Clinical Development: Why Fill2Weight Matters

Formulation Freedom in Clinical Development: Why Fill2Weight Matters

Chris Webster: 1 June 2026

In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...

Read More